Síntese e avaliação da ação antitumoral de derivados 1,2,4-oxadiazólicos em modelos in vitro de linhagens de tumores humanos e animais
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Cancer is among one of the biggest causes of deaths in the world. It is well known that
incidence and mortality related with this disease are increasing, also there is a deficiency in
chemotherapeutic treatment; so, the scientific society still looking for new compounds that
show antitumor activity and have greater efficiency and high selectivity. Considering the
panorama, this work consists in the synthesis and evaluation of antitumor activity of 1,2,4-
oxadiazolic derivatives substituted in positions 3 and 5. Twenty-two compounds were
synthesized from three different nitriles with hydroxylamine, generating three amidoximes.
Then the reaction of amidoximes with bromo acetyl bromide followed by cyclization led to
three 5-(bromomethyl)-1,2,4-oxadiazole intermediates. Further, more six other oxadiazol
derivatives were obtained by action of these three intermediates with ethylenediamine,
propanediamine, butanediamine and piperazine. Finally, more ten compounds were synthesized
by reaction of three piperazine-containing derivatives with long chain alkyl halides. All
synthesized compounds had their structures elucidated by infrared and 1H and 13C NMR spectra.
All compounds were evaluated for antitumor activity by cytotoxicity assay for IC50 and
selectivity index (SI) determination in animal and human cell lines. The synthesized compounds
showed significant cytotoxicity and selectivity against animal tumor cell lines B16F10 (6,0 ±
2,2 μM ≤ IC50 ≤ 27,6 ± 5,1 μM; 0,5 ≤ SIBHK-21 ≤ 2,5) e CT26-WT (2,5 ± 0,7 μM ≤ IC50 ≤ 36,1
± 2,4 μM; 0,5 ≤ SIBHK-21 ≤ 4,9). Specially three 5-(bromomethyl)-1,2,4-oxadiazole
intermediates and N-alkylated oxadiazoles containing 12 carbon chain. Against human tumor
cell line RKO-AS45-1 were obtained IC50 values between 29,2μg/mL and 672 μg/mL with
selective index (SIWI-26 VA4) lower than 2,0. Cell death by apoptosis was evaluated for two of
the most cytotoxic and selective compounds (compounds 20 and 22) in RKO-AS45-1 (human
colon carcinoma) and WI-26 VA4 (human lung fibroblast) cell lines. With these data it was
possible to observe that compound 22 induced death by necrosis, undesirable mechanism of
cell death, since it can generate inflammatory processes and other side effects. On the other
hand, the treatment with compound 20 induced little cell death, so, its cytotoxicity may be
related with other mechanism that regulate cell function. Until now, preliminary results from
cellular cycle analysis by flow cytometry indicates that cells treated with compound 20 lead to
stay in G1 phase.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
